Therapeutic Solutions International Signs Memorandum of Understanding with Clinical Stage Immunotherapy Company Eutilogics, Inc. to Explore Augmentation of Synergies between StemVacs-V and TAST

Author's Avatar
Sep 07, 2021

Phase III Cell Therapy Company to Leverage Clinical and Immunological Experience of Korean Clinical Developments to Develop Cancer Killing Therapies

PR Newswire